MARUBBI, DANIELA
 Distribuzione geografica
Continente #
EU - Europa 1.710
Totale 1.710
Nazione #
IT - Italia 1.710
Totale 1.710
Città #
Genova 1.323
Genoa 208
Rapallo 175
Bordighera 4
Totale 1.710
Nome #
The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma 163
Noninvasive Monitoring of Glioma Growth in the Mouse 127
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures 117
Pharmacokinetics, pharmacodynamics and efficacy on pediatric tumors of the glioma radiosensitizer KU60019 111
Progression from low-to high-grade in a glioblastoma model reveals the pivotal role of immunoediting 110
Predictability, efficacy and safety of radiosensitization of glioblastoma-initiating cells by the ATM inhibitor KU-60019. 102
Eradication of glioblastoma by immuno-virotherapy with a retargeted oncolytic HSV in a preclinical model 102
Cdh4 Down-Regulation Impairs in Vivo Infiltration and Malignancy in Patients Derived Glioblastoma Cells 101
The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells 100
Sox2 silencing in glioblastoma tumor initiating cells causes stop of proliferation and loss of tumorigenicity 97
Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration 97
Different response of human glioma tumor-initiating cells to EGFR kinase inhibitors. 95
Faithful animal modelling of human glioma by using primary initiating cells and its implications for radiosensitization therapy [ARRIVE 1] 80
Glioblastoma models driven by different mutations converge to the proneural subtype 62
Natural Killer cells recognize and kill human glioblastoma cells with stem cell-like properties 58
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A 58
Immunoescape during glioma progression 47
Common features between EGFRVIII and Pdgf-b induced gliomas models. 46
Modeling immunoediting in glioma progression 45
modeling immunoediting in glioma progression 34
Early clonal extinction in glioblastoma progression revealed by genetic barcoding 26
Totale 1.778
Categoria #
all - tutte 5.287
article - articoli 4.620
book - libri 0
conference - conferenze 667
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.574


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201986 0 0 0 0 0 0 0 0 0 0 45 41
2019/2020525 17 15 28 29 47 70 70 45 50 82 56 16
2020/2021226 11 14 14 33 34 14 6 17 13 40 16 14
2021/2022264 16 21 9 27 3 25 13 59 20 24 13 34
2022/2023205 18 21 6 25 23 26 3 18 26 0 37 2
2023/2024185 4 22 10 31 25 48 13 10 12 10 0 0
Totale 1.778